Genetic Profiling Analysis Design of Well-Differentiated Aggressive Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors in the Phase III Randomized Controlled COMPOSE Trial.
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Pancreatic Neuroendocrine Tumors,Neuroendocrine Tumors,Gastroenteropancreatic Neoplasms,Peptide Receptor Radionuclide Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined